TipRanks
Vivoryon Therapeutics AG (DE:05Y)
FRANKFURT:05Y
Germany Market
05Y
Vivoryon Therapeutics AG
RESEARCH TOOLSreports

Vivoryon Therapeutics AG (05Y) Cash flow

40 Followers

Vivoryon Therapeutics AG Cash Flow

DE:05Y's free cash flow for Q2 2026 was €-3.15M. For the 2026 fiscal year, DE:05Y's free cash flow was decreased by €10.71M and operating cash flow was €-3.15M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
€ -8.46M€ -19.17M€ -21.54M€ -21.79M€ -11.26M
Investing Cash Flow
€ -6.00K€ 10.00M€ -10.51M€ -13.00K€ -28.00K
Financing Cash Flow
€ 4.71M€ -57.00K€ 24.16M€ 33.38M€ -827.00K
End Cash Position
€ 5.62M€ 9.37M€ 18.56M€ 26.55M€ 14.66M
Free Cash Flow
€ -8.46M€ -19.18M€ -22.05M€ -21.81M€ -11.29M
Currency in EUR

Vivoryon Therapeutics AG Cash Flow